🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate time to progression, overall survi...
Status
Completed
Location
Multiple Locations
Start Date
2004-12
Trial ID
NCT00103506
Treatments Being Tested
This clinical trial is evaluating tucatinib in combination with Doxil in pa...
Status
Recruiting
Location
Maryland Oncology Hematology
Start Date
2023-07-24
Trial ID
NCT05748834
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Unknown
Location
New England Medical Center Hospital
Start Date
1998-01
Trial ID
NCT00003296
Treatments Being Tested
The purpose of this study is to compare the effectiveness between CAELYX an...
Status
Terminated
Location
Multiple Locations
Start Date
2013-06
Trial ID
NCT01840943
Treatments Being Tested
Objectives: Phase I part * Primary Objective: To determine the recommende...
Status
Terminated
Location
China Medical University Hospital
Start Date
2012-07
Trial ID
NCT01658358
To determine the efficacy of Stealth liposomal doxorubicin hydrochloride (D...
Status
Completed
Location
Beth Israel Hosp
Start Date
TBD
Trial ID
NCT00002105
Treatments Being Tested
Phase II trial to study the effectiveness of combination chemotherapy with ...
Status
Completed
Location
Eastern Cooperative Oncology Group
Start Date
2001-01
Trial ID
NCT00004888
This phase I trial studies the side effects and how well surgery and heated...
Status
Active Not Recruiting
Location
City of Hope Corona
Start Date
2014-05-19
Trial ID
NCT01970722
The purpose of this study is to determine whether doxorubicin hydrochloride...
Status
Unknown
Location
the First Affiliated Hospital of Soochow University
Start Date
2015-10
Trial ID
NCT02577783
Leptomeningeal metastases (LM) develop when tumor cells reach the cerebrosp...
Status
Unknown
Location
the Netherlands Cancer Institute - Antoni van Leeuwenhoek
Start Date
2013-10
Trial ID
NCT01818713
Treatments Being Tested